ApoB for South Asians and Indians: Why This Community Faces Higher Heart Risk
South Asians develop heart disease earlier and at lower BMIs than other populations. ApoB is the single most useful blood test to surface that hidden risk — here is why it matters and what to do about it.
April 28, 2026 · Blood Vessels & Heart
If you are South Asian — Indian, Pakistani, Bangladeshi, Sri Lankani, or Nepali — you carry one of the highest cardiovascular risk profiles of any population on earth. Heart disease tends to show up roughly a decade earlier than in other groups, often at body weights that look perfectly healthy on paper.
Standard cholesterol panels routinely miss this. ApoB, a single blood test, surfaces the risk with far more precision. Here is what makes the South Asian lipid picture different, and why ApoB belongs on every screening.
TL;DR
- South Asians have up to a 4x higher risk of heart disease than the general population, and events occur ~10 years earlier on average.
- Standard LDL cholesterol can read “normal” while ApoB is high — South Asians often carry small, dense LDL particles that pack more atherogenic particles into the same cholesterol number.
- Lipoprotein(a), or Lp(a), is also elevated in 25–35% of South Asians. It is genetic, lifelong, and only measured if you ask.
- Aim for ApoB under 80 mg/dL if you are otherwise healthy, and under 60 mg/dL if you have any other risk factors.
- Diet, weight, and exercise move ApoB substantially. Statins, ezetimibe, and PCSK9 inhibitors close whatever gap remains.
Why South Asian Heart Risk Is Different
Decades of large cohort studies — INTERHEART, MASALA, the UK Biobank — converge on the same finding: South Asians develop atherosclerotic cardiovascular disease (ASCVD) earlier and more aggressively than European, East Asian, or African populations matched on weight, smoking, and standard cholesterol levels.
The drivers cluster into three buckets:
Lipoprotein particle profile. South Asians tend to carry more small, dense LDL particles. Two people can have the same LDL cholesterol number while one has many small particles and the other has fewer large ones. The first profile is far more atherogenic — small particles slip into the artery wall more easily, oxidize faster, and trigger more inflammation. ApoB counts the particles directly. LDL cholesterol does not.
Lipoprotein(a). Lp(a) is a genetically determined LDL-like particle that is elevated (>50 mg/dL or >125 nmol/L) in roughly 25–35% of South Asians, versus ~20% of the global population. It is independent of diet and exercise. Most people never get tested for it because it is not on the standard panel.
Metabolic syndrome at low BMI. South Asians accumulate visceral fat — the metabolically active fat around the organs — at lower BMIs than other groups. Insulin resistance, high triglycerides, low HDL, and elevated ApoB often appear in people who look lean by BMI charts. The American Diabetes Association now uses a BMI cutoff of 23 (rather than 25) for diabetes screening in South Asians for this reason.
The combined effect: a 35-year-old South Asian man with a “normal” LDL of 110 mg/dL can already be carrying significant plaque burden that a standard panel would not flag.
How South Asians Compare to East Asians and Whites
The risk profile is genuinely different across populations. The numbers below are broad averages from cohort studies (INTERHEART, MASALA, MESA, UK Biobank) — individuals vary, but the pattern is consistent enough to change how each group should be screened.
| Dimension | South Asian | East Asian | White (European) |
|---|---|---|---|
| Relative heart disease risk | ~3–4x | ~0.7–0.9x | 1x (reference) |
| Typical age of first heart attack | ~50 (men), ~55 (women) | ~62 | ~60 |
| BMI cutoff for diabetes screening | 23 | 23 | 25 |
| Waist cutoff (men / women) | 35 in / 31 in | 35 in / 31 in | 40 in / 35 in |
| Visceral fat at given BMI | Highest | Moderate | Lowest |
| Small dense LDL pattern (Pattern B) | Common (~40–50%) | Less common (~25%) | Less common (~25–30%) |
| Lp(a) elevated (>50 mg/dL) | 25–35% | 10–15% | ~20% |
| LDL cholesterol mean (mg/dL) | Often “normal” (110–130) | Lower (90–110) | Higher (115–135) |
| ApoB / LDL discordance (LDL looks fine, ApoB high) | Common | Less common | Less common |
| Stroke vs heart attack pattern | Heart attack predominant | Stroke (especially hemorrhagic) more prominent | Heart attack predominant |
| Sensitivity to refined carbs | Highest (rice/wheat staples) | High | Moderate |
| Statin response | Strong; lower doses often effective | Strong; lower doses often effective | Standard |
A few takeaways from the table:
- East Asians have lower LDL on average but a different pattern of cardiovascular disease — stroke (especially hemorrhagic stroke linked to hypertension) is relatively more common than heart attack. ApoB is still useful, but blood pressure and homocysteine deserve equal attention.
- Whites have the highest mean LDL but a lower particle-count discordance — LDL cholesterol is a reasonable proxy for risk in this group, so the gap between LDL and ApoB matters less.
- South Asians sit at the intersection of the worst features of both — modest LDL numbers that hide a high particle count, plus elevated Lp(a), plus visceral adiposity at low BMI. This is why ApoB is more clinically useful for South Asians than for either of the other groups.
Why ApoB Outperforms LDL for This Population
Every atherogenic lipoprotein particle — LDL, VLDL, IDL, Lp(a) — carries exactly one ApoB molecule. So ApoB is a direct count of the particles that cause atherosclerosis.
LDL cholesterol, by contrast, measures the cholesterol cargo inside one subset of those particles. When particles are small and dense, you get more particles per unit of cholesterol, and LDL underestimates risk. When triglycerides are high (also common in South Asians), the standard Friedewald-calculated LDL becomes especially unreliable.
Studies consistently show ApoB is a stronger predictor of heart attack and stroke than LDL cholesterol, and the discordance between the two — where LDL looks fine but ApoB is high — is more common in South Asians than in any other group.
If you only get one lipid number, ApoB is the one.
ApoB Targets
National guidelines do not yet specify population-specific cutoffs, and there is no defined lower limit for ApoB — lower is generally better. Practical targets:
- Under 80 mg/dL — optimal for adults with no other risk factors.
- Under 60 mg/dL — recommended if you have diabetes, established cardiovascular disease, family history of early heart attack, or elevated Lp(a).
- 80–99 mg/dL — moderate risk, intervention warranted given the South Asian baseline.
- 100+ mg/dL — high risk regardless of background.
For South Asians specifically, many lipidologists argue the threshold to start treatment should be lower than the general population, because the lifetime exposure required to develop disease is reached at younger ages.
What to Test Alongside ApoB
A single ApoB number is useful. ApoB plus a few companion markers is much more useful, especially for this population:
- Lipoprotein(a) — measure once in your life. If it is high, you have a hereditary risk you cannot diet your way out of, and your ApoB target shifts lower.
- hsCRP — inflammation marker. Elevated hsCRP plus elevated ApoB is a worse combination than either alone.
- Fasting insulin and glucose — surfaces the insulin resistance that drives the small-dense-LDL pattern. Often abnormal in South Asians while HbA1c is still normal.
- Triglycerides and HDL — the triglyceride-to-HDL ratio is a quick proxy for particle size. A ratio above 2.0 (in mg/dL) suggests small, dense LDL.
- LDL particle count and size — direct confirmation of the dense-particle pattern if you want it.
Lifestyle Changes That Move ApoB
ApoB is highly modifiable. Most people see meaningful drops within 8–12 weeks of consistent change.
Diet. Replace saturated fat (ghee, full-fat dairy, fatty cuts of meat, coconut oil) with unsaturated fats (olive oil, fatty fish, nuts, seeds, avocado). Cut refined carbohydrates — white rice, refined wheat, sugar — which drive triglycerides and small dense LDL in this population. South Asian diets are often built around white rice and refined flour; swapping to brown rice, millet, oats, lentils, and vegetables typically produces the largest single drop in ApoB.
Soluble fiber. 25–30 g/day. Oats, beans, lentils, chia, psyllium, brussels sprouts, apples. Soluble fiber binds bile acids in the gut, forcing the liver to pull cholesterol out of circulation to make more.
Weight and visceral fat. A 5–10% reduction in body weight typically moves ApoB by 10–15 mg/dL. Waist circumference matters more than BMI — under 35 inches for men and under 31 inches for women is the South-Asian-specific cutoff.
Exercise. 150 minutes/week of moderate aerobic activity, plus resistance training 2–3 times per week. Aerobic exercise improves HDL and triglyceride profile; resistance training improves insulin sensitivity, which shifts you toward the larger, less-atherogenic LDL pattern.
Sleep, stress, alcohol. All three influence triglycerides and insulin resistance, which feed back into the ApoB number. The basics matter.
When Lifestyle Is Not Enough
If you have done the work — diet, weight, exercise — for 3–6 months and ApoB is still above your target, medication is warranted. South Asians often respond well to statins, and the absolute risk reduction is larger than for lower-risk populations because the baseline risk is higher.
Ezetimibe and PCSK9 inhibitors are options if statins alone do not get you there, or if you have elevated Lp(a) and need an aggressive ApoB target. This is a conversation to have with a physician who understands the South Asian lipid picture.
The point is not to avoid medication. The point is to know your number, set the right target for your background, and use whatever combination of lifestyle and pharmacology gets you there.
Bottom Line
If you are South Asian, the standard cholesterol panel your primary care doctor orders is not enough. ApoB is the single best test for the kind of cardiovascular risk this population actually has. Get it once to know your baseline, and again every 1–3 years depending on your number and family history. Pair it with a one-time Lp(a) test. Then act on whatever the numbers tell you.
The earlier you catch elevated ApoB, the more years of artery-wall exposure you avoid — and for South Asians, those years compound faster than for almost anyone else.
